Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
1,989,572
-
Share change
-
+1,472,087
-
Total reported value
-
$3,403,019
-
Price per share
-
$1.71
-
Number of holders
-
20
-
Value change
-
+$2,451,840
-
Number of buys
-
11
-
Number of sells
-
6
Institutional Holders of VTV THERAPEUTICS INC - CL A (VTVT) as of Q1 2019
As of 31 Mar 2019,
VTV THERAPEUTICS INC - CL A (VTVT) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,989,572 shares.
The largest 10 holders included
CVI Holdings, LLC, SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, BlackRock Inc., BARCLAYS PLC, MORGAN STANLEY, and WEDBUSH SECURITIES INC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.